July 29, 2019 | Letisia Marquez
City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.
Michael Amini Transfusion Medicine Center celebrates 10th anniversary
July 12, 2019 | Michael Easterling
A visionary gift from Michael Amini led the way for the construction of a new, centralized state-of-the art blood donation and cell-processing facility that opened in 2009 and bears his name.
Bone marrow transplants have broken the age barrier
May 7, 2019 | Abe Rosenberg
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient. Today, age is no longer a barrier to transplant.
15,000 second chances: Bone Marrow Transplant program celebrates new milestone
April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
As leading-edge treatments take center stage, blood donors become increasingly critical
January 25, 2019 | Maxine Nunes
City of Hope’s work would be impossible without blood and platelet donors. In recent years, leading-edge cancer research has given City of Hope some remarkable advances in cancer treatment. But these same breakthroughs have also placed a greater demand on blood supply.
CAR T Laboratory Research Yields Promising Prostate Cancer Results
April 17, 2018 | Letisia Marquez
City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.
‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma
March 6, 2018 | City of Hope
Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.